Soros Fund Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-201,903
Closed -$34.9M 320
2015
Q1
$34.9M Sell
201,903
-289,628
-59% -$42.5M 0.34% 78
2014
Q4
$56.5M Buy
+491,531
New +$59.5M 0.62% 49

Other funds holding SLXP

Soros Fund Management's SLXP Position: Q2 2015 in Review

Soros Fund Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 201,903 shares — an estimated $34.9M sold.

Soros Fund Management first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $56.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Soros Fund Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Soros Fund Management sold 201,903 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $34.9M.
  • Soros Fund Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Soros Fund Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $56.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Soros Fund Management's 13F filing for Q2 2015, filed 14 Aug 2015.